Endogenous TGF-β activity limits TSLP expression in the intervertebral disc tissue by suppressing NF-κB activation

Journal of Orthopaedic Research

Volumn 31, Issue 7, 2013, Pages 1144-1149

  Zhu, Yong ^a,b   Ohba, Tetsuro ^a   Ando, Takashi ^a   Fujita, Koji ^a   Koyama, Kensuke ^a   Nakamura, Yuki ^a   Katoh, Ryohei ^a   Haro, Hirotaka ^a   Nakao, Atsuhito ^a,c  

^a UNIVERSITY OF YAMANASHI   (Japan)

^b INNER MONGOLIA MEDICAL COLLEGE   (China)

^c JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

herniated disc; intervertebral disc; TGF ; TSLP

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; SMAD2 PROTEIN; SMAD3 PROTEIN; THYMIC STROMAL LYMPHOPOIETIN; TRANSFORMING GROWTH FACTOR BETA;

ADULT; AGED; ANIMAL TISSUE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; GENE ACTIVITY; GENE EXPRESSION; GENE REPRESSION; HUMAN; HUMAN TISSUE; INTERVERTEBRAL DISK; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; REGULATORY MECHANISM; SPINE FUSION; STEADY STATE; TISSUE CULTURE;

ADULT; AGED; ANIMALS; CELLS, CULTURED; CYTOKINES; HOMEOSTASIS; HUMANS; INTERVERTEBRAL DISC; INTERVERTEBRAL DISC DISPLACEMENT; MICE; MICE, INBRED C57BL; MIDDLE AGED; MODELS, ANIMAL; NF-KAPPA B; PHOSPHORYLATION; SIGNAL TRANSDUCTION; SMAD2 PROTEIN; SMAD3 PROTEIN; TISSUE CULTURE TECHNIQUES; TRANSFORMING GROWTH FACTOR BETA;

EID: 84878179789     PISSN: 07360266     EISSN: 1554527X     Source Type: Journal    
DOI: 10.1002/jor.22337     Document Type: Article

References (23)

1. Borenstein DG., 2001. Epidemiology, etiology, diagnostic evaluation, and treatment of low back pain. Curr Opin Rheumatol 13: 128-134. (Pubitemid 32205375)
2. Richardson SM, Mobasheri A, Freemont AJ, et al. 2007. Intervertebral disc biology, degeneration and novel tissue engineering and regenerative medicine therapies. Histol Histopathol 22: 1033-1041. (Pubitemid 47034169)
3. Deyo RA, Weinstein JN., 2001. Low back pain. N Engl J Med 344: 363-370. (Pubitemid 32107646)
4. Haro H, Shinomiya K, Komori H, et al. 1996. Upregulated expression of chemokines in herniated nucleus pulposus resorption. Spine (PhilaPa 1976) 21: 1647-1652. (Pubitemid 26250561)
5. Komori H, Shinomiya K, Nakai O, et al. 1996. The natural history of herniated nucleus pulposus with radiculopathy. Spine (PhilaPa 1976) 21: 225-229. (Pubitemid 26041221)
6. Haro H, Crawford HC, Fingleton B, et al. 2000. Matrix metalloproteinase-3-dependent generation of a macrophage chemoattractant in a model of herniated disc resorption. J Clin Invest 105: 133-141. (Pubitemid 30054352)
7. Haro H, Crawford HC, Fingleton B, et al. 2000. Matrix metalloproteinase-7-dependent release of tumor necrosis factor-α in a model of herniated disc resorption. J Clin Invest 105: 143-150. (Pubitemid 30054353)
8. Haro H, Kato T, Komori H, et al. 2002. Vascular endothelial growth factor (VEGF)-induced angiogenesis in herniated disc resorption. J Orthop Res 20: 409-415. (Pubitemid 34460996)
9. Ziegler SF, Liu YJ., 2006. Thymic stromal lymphopoietin in normal and pathogenic T cell development and function. Nat Immunol 7: 709-714. (Pubitemid 43905869)
10. Ohba T, Haro H, Ando T, et al. 2008. A potential role of thymic stromal lymphopoietin in the recruitment of macrophages to mouse intervertebral disc cells via monocyte chemotactic protein 1 induction: implications for herniated discs. Arthritis Rheum 58: 3510-3519.
11. Takai T., 2012. TSLP expression: cellular sources, triggers, and regulatory mechanisms. Allergol Int 61: 3-17.
12. Heldin CH, Moustakas A., 2012. Role of Smads in TGF-β signaling. Cell Tissue Res 347: 21-36.
13. Ishida W, Mori Y, Lakos G, et al. 2006. Intracellular TGF-β receptor blockade abrogates Smad-dependent fibroblast activation in vitro and in vivo. J Invest Dermatol 126: 1733-1744. (Pubitemid 44086506)
14. Laping NJ, Grygielko E, Mathur A, et al. 2002. Inhibition of transforming growth factor (TGF)-β1-induced extracellular matrix with a novel inhibitor of the TGF-β type I receptor kinase activity: SB-431542. Mol Pharmacol 62: 58-64. (Pubitemid 34680516)
15. Yoshida M, Nakamura T, Kikuchi T, et al. 2002. Expression of monocyte chemoattractant protein-1 in primary cultures of rabbit intervertebral disc cells. J Orthop Res 20: 1298-1304. (Pubitemid 35363988)
16. Fujita K, Ando T, Ohba T, et al. 2012. Age-related expression of MCP-1 and MMP-3 in mouse intervertebral disc in relation to TWEAK and TNF-α stimulation. J Orthop Res 30: 599-605.
17. Finnson KW, Chi Y, Bou-Gharios G, et al. 2012. TGF-β signaling in cartilage homeostasis and osteoarthritis. Front Biosci (Schol Ed) 4: 251-268.
18. Patil AS, Sable RB, Kothari RM., 2011. An update on transforming growth factor-β (TGF-β): sources, types, functions and clinical applicability for cartilage/bone healing. J Cell Physiol 226: 3094-3103.
19. Ramirez F, Rifkin DB., 2009. Extracellular microfibrils: contextual platforms for TGF-β and BMP signaling. Curr Opin Cell Biol 21: 616-622.
20. Keski-Oja J, Koli K, von Melchner H., 2004. TGF-β activation by traction ? Trends Cell Biol 14: 657-659.
21. Massagué J., 2012. TGF-β signalling in context. Nat Rev Mol Cell Biol 13: 616-630.
22. Haller D, Holt L, Kim SC, et al. 2003. Transforming growth factor-β1 inhibits non-pathogenic Gram negative bacteria-induced NF-κB recruitment to the interleukin-6 gene promoter in intestinal epithelial cells through modulation of histone acetylation. J Biol Chem 278: 23851-23860. (Pubitemid 36830211)
23. Bitzer M, von Gersdorff G, Liang D, et al. 2000. A mechanism of suppression of TGF-β/SMAD signaling by NF-κB/RelA. Genes Dev 14: 187-197. (Pubitemid 30070984)